Unresectable Malignant Solid Neoplasm Recruiting Phase 1 Trials for Tuvusertib (DB18790)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0110416 (Unresectable Malignant Solid Neoplasm) | Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05687136 | Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and M1774 for Advanced Solid Tumors | Treatment |